Literature DB >> 6761348

Transforming genes in human tumors.

S Pulciani, E Santos, A V Lauver, L K Long, M Barbacid.   

Abstract

DNAs isolated from a variety of human tumor cell lines as well as from naturally occurring human carcinomas and sarcomas were shown to induce morphologic transformation upon transfection into NIH/3T3 cells. All tested transformants contained human DNA sequences, some of which specifically cosegregated with the malignant phenotype in additional cycles of transfection. Southern blot analysis of second cycle transformants derived from T24 human bladder carcinoma cells showed the presence of a single 15 kbp EcoRI fragment of human DNA. These sequences were molecularly cloned utilizing lambda Charon 9A as the cloning vector. The resulting recombinant DNA molecule, designated lambda T24-15A, was shown to contain an internal 6.6 kbp Bam HI fragment of human DNA that transformed NIH/3T3 fibroblasts with a specific activity of 5 X 10(4) focus forming units per picomole. These results indicate that we have molecularly cloned an oncogene present in T24 bladder carcinoma cells. Comparison of molecular clones containing the T24 oncogene and its normal homologue did not reveal biochemical differences that helped to explain the malignant properties of this oncogene. Finally, we report preliminary results indicating that the T24 bladder carcinoma oncogene is highly related to the transforming gene of BALB-MSV, an acute transforming retrovirus.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 6761348     DOI: 10.1002/jcb.240200106

Source DB:  PubMed          Journal:  J Cell Biochem        ISSN: 0730-2312            Impact factor:   4.429


  19 in total

1.  Persistence of Ha-ras-induced metastatic potential of SP1 mouse mammary tumors despite loss of the Ha-ras shuttle vector.

Authors:  B Schlatter; C G Waghorne
Journal:  Proc Natl Acad Sci U S A       Date:  1992-11-01       Impact factor: 11.205

2.  The interleukin-1 receptor in Raji human B-lymphoma cells. Molecular characterization and evidence for receptor-mediated activation of gene expression.

Authors:  R Horuk; J A McCubrey
Journal:  Biochem J       Date:  1989-06-15       Impact factor: 3.857

3.  EGFRvIV: a previously uncharacterized oncogenic mutant reveals a kinase autoinhibitory mechanism.

Authors:  G Pines; P H Huang; Y Zwang; F M White; Y Yarden
Journal:  Oncogene       Date:  2010-08-02       Impact factor: 9.867

4.  Differential expression of the homeobox gene Hox-1.3 in F9 embryonal carcinoma cells.

Authors:  S P Murphy; J Garbern; W F Odenwald; R A Lazzarini; E Linney
Journal:  Proc Natl Acad Sci U S A       Date:  1988-08       Impact factor: 11.205

5.  General method for quantifying base adducts in specific mammalian genes.

Authors:  D C Thomas; A G Morton; V A Bohr; A Sancar
Journal:  Proc Natl Acad Sci U S A       Date:  1988-06       Impact factor: 11.205

6.  A new cell line from human infiltrating ductal carcinoma of the breast: establishment and characterization.

Authors:  W Zoli; L Roncuzzi; A Flamigni; R Gruppioni; A Sensi; N Zini; D Amadori; A Gasperi-Campani
Journal:  J Cancer Res Clin Oncol       Date:  1996       Impact factor: 4.553

7.  Human papillomavirus type 16 DNA-induced malignant transformation of NIH 3T3 cells.

Authors:  S Yasumoto; A L Burkhardt; J Doniger; J A DiPaolo
Journal:  J Virol       Date:  1986-02       Impact factor: 5.103

8.  Reduced hormone-stimulated adenylate cyclase activity in NIH-3T3 cells expressing the EJ human bladder ras oncogene.

Authors:  W G Tarpley; N K Hopkins; R R Gorman
Journal:  Proc Natl Acad Sci U S A       Date:  1986-06       Impact factor: 11.205

9.  Analysis of Ha-ras 1 allele frequencies in hereditary non-polyposis colorectal cancer.

Authors:  P Jeevaratnam; P J Browett; N S Van de Water; J R Jass
Journal:  Gut       Date:  1995-03       Impact factor: 23.059

10.  Alteration of the tumorigenic and metastatic properties of neoplastic cells is associated with the process of calcium phosphate-mediated DNA transfection.

Authors:  R S Kerbel; C Waghorne; M S Man; B Elliott; M L Breitman
Journal:  Proc Natl Acad Sci U S A       Date:  1987-03       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.